Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
01/2010
01/21/2010WO2010009215A1 Nicotinic acid receptor agonist compounds useful to treat metabolic syndromes
01/21/2010WO2010008746A1 Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
01/21/2010WO2010007327A2 Manufacture of maleic anhydride from renewable materials, maleic anhydride obtained and uses thereof
01/21/2010WO2010007139A1 Process for the oxidation of alcohol and/or aldehyde groups
01/21/2010WO2010007022A1 Synthesis of 6,7-dihydro-1h-indeno[5,4-b]furan-8(2h)-one as intermediate in the preparation of ramelteon
01/21/2010WO2009141718A3 Process for the preparation of prostaglandin analogues and intermediates thereof
01/21/2010US20100016424 Production and use of derivatized homoserine lactones
01/21/2010US20100016295 Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity
01/21/2010US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
01/21/2010CA2730260A1 Process for the oxidation of alcohol and/or aldehyde groups
01/21/2010CA2730224A1 Synthesis of 6,7-dihydro-1h-indeno[5,4-b]furan-8(2h)-one as intermediate in the preparation of ramelteon
01/20/2010EP2145881A1 Antiarrhythmic precursor compounds, methods of synthesis and methods of use
01/20/2010EP2144893A2 Tricyclic compounds as matrix metalloproteinase inhibitors
01/20/2010EP2144866A1 Method for preparing 2-(n-butyl)-5-nitrobenzofuran
01/20/2010EP1654247B1 Alkynyl aryl carboxamides
01/20/2010EP1568701B1 Transition metal complex having diphosphine complex as ligand
01/20/2010EP1555257B1 Process for producing aromatic nitrile compound
01/20/2010EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives
01/20/2010CN101628904A Synthesis method of 2-nitro-3-aryl-2,3,5,7-tetrahydrobenzofuran-4-one derivative
01/20/2010CN101628903A Defervescence anti-inflammatory and anti-infection medicine with immunization function, preparation and application thereof
01/20/2010CN101628902A Method for preparing 5-hydroxymethylfurfural by taking glucose as raw material
01/20/2010CN101628901A Method for preparing 5-hydroxymethylfurfural by taking cellulose as raw material
01/20/2010CN100582100C Industrial benzene anhydride of preventing storage colour-change and its preparing method
01/20/2010CN100582097C Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
01/20/2010CN100582087C 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative
01/20/2010CN100582084C Hydrophobic polyamine analogs and methods for their use
01/19/2010US7649085 Saquinavir conjugates and antibodies useful in immunoassay
01/19/2010US7649055 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
01/19/2010US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
01/19/2010US7649005 Substituted benzylaminoalkylene heterocycles
01/19/2010US7649001 Fused benzene derivative and use
01/19/2010US7648742 Difluorosubstituted heterocyclic compounds and the use thereof in the form of components in liquid crystalline media
01/19/2010CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors
01/14/2010WO2010006123A2 19-nor-vitamin d analogs with 1,2-dihydrofuran ring
01/14/2010WO2010006121A2 19-nor-vitamin d analogs with 3,2-dihydrofuran ring
01/14/2010WO2010004957A1 Chiral iridium aqua complex and method for producing optically active hydroxy compound using the same
01/14/2010WO2010004575A2 Preparation of escitalopram, its salts and intermediates
01/14/2010US20100010239 Process for the Production of Prostaglandins and Prostaglandin Analogs
01/14/2010US20100010238 Process for producing a ringlike oxidic shaped body
01/14/2010US20100010124 Lactone stabilizing compositions
01/14/2010US20100010082 Formulations for treating eye disorders
01/14/2010US20100010063 Heterocyclocarboxamide derivatives
01/14/2010US20100010012 Glutamate aggrecanase inhibitors
01/14/2010US20100010004 Inhibitors of histone deacetylase
01/14/2010US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
01/14/2010US20100009945 3,2-dihydrofuran-1 alpha ,25-dihydroxy-19-nor-vitamin D3; prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases; osteoporosis
01/14/2010US20100009944 19-Nor-Vitamin D Analogs with 1,2-Dihydrofuran Ring
01/14/2010US20100009935 Resistance-repellent retroviral protease inhibitors
01/14/2010US20100009850 Iodine-phenyl-substituted cyclic cetoenols
01/13/2010EP2143712A1 Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
01/13/2010EP2142524A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
01/13/2010EP2142511A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
01/13/2010EP2142505A1 Sulfonamides and pharmaceutical compositions thereof
01/13/2010EP2142503A2 Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof
01/13/2010EP2141990A1 11beta-hsd1 active compounds
01/13/2010EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions
01/13/2010CN101624387A Method for purifying and preparing isoalantolactone and application thereof in preparing antineoplastic medicaments
01/13/2010CN100579972C Method for the distillative processing of tetrahydrofuran
01/13/2010CN100579948C Halogen compound carbonylation reaction method
01/13/2010CN100579654C Complex acid catalyst
01/12/2010US7645878 Reacting an aniline derivative with an acylchloride to form an intermeidate, cyclizing the intermediate, replacing hydroxy group with a leaving group (chloride), racting the product with an amino-heterocyclic compound
01/12/2010CA2442906C Reconstitutable parenteral composition containing a cox-2 inhibitor
01/12/2010CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
01/12/2010CA2403835C Anti-viral pyrimidine nucleoside analogues
01/12/2010CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
01/12/2010CA2346010C Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance
01/07/2010WO2010002209A2 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
01/07/2010WO2010000773A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
01/07/2010WO2009121535A3 Antiproliferative compounds and therapeutic uses thereof
01/07/2010WO2008148790A8 Anti -inflammatory substituted cyclobutenedione compounds
01/07/2010WO2008017346A3 Ascorbic acid derivatives, use thereof for the functionalization of matrices
01/07/2010US20100004437 Chemical Transformation of Lignocellulosic Biomass into Fuels and Chemicals
01/07/2010US20100004328 COMPOUND, Alpha1 ADRENERGIC RECEPTOR ANTAGONISTIC AGENT, AND COMPOSITION
01/07/2010US20100004312 Fused cyclic compounds
01/07/2010US20100004241 Non-imidazole aryloxyalkylamines
01/07/2010US20100004208 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
01/07/2010US20100003191 Aurone derivative-containing composition for diagnosis
01/07/2010US20100001636 Aromatic amine derivative and organic electroluminescence device
01/07/2010CA2729724A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
01/06/2010EP2141156A1 Process for Preparation of Citalopram and Enantiomers
01/06/2010EP2139900A2 Novel functional compounds with an isosorbide or isosorbide isomer core, production process and uses of these compounds
01/06/2010EP1562911B1 Compositions useful as inhibitors of jak and other protein kinases
01/06/2010EP1489078B1 Benzofuran derivative
01/06/2010CN101622237A Method for continuously producing 2,5-dihydrofuran
01/06/2010CN101619052A Methanol waste gas recovery technology in vitamin C producing process
01/06/2010CN101619051A Preparation method of hydroxymethylfurfural
01/06/2010CN101619050A Method for preparing 2,5-diformyl furan by catalyzing 5-hydroxy methyl furfural
01/06/2010CN101619049A Preparation method of gamma-butyrolactone and 2,3-dihydrofuran
01/06/2010CN100577677C Caulis trachelospermi total lignans extractive, extraction method and medicine use of the active constituent thereof
01/06/2010CN100577655C Andrographolidi natrii bisulfis and preparation method thereof
01/06/2010CN100577654C Process for the production of ethers
01/06/2010CN100577633C CaSR antagonist
01/06/2010CN100577182C Emulsion containing aucklandia root oil, its preparation process and use
01/06/2010CN100577163C Compounds effecting glucokinase
01/05/2010US7642367 Diamino-functional chalcones
01/05/2010US7642361 Thiophene and furan compounds
01/05/2010US7642277 Non-nucleoside reverse transcriptase inhibitors
01/05/2010US7642272 Cannabinoid receptor ligands
01/05/2010US7641922 Preparation and application of transhintotalphenolic acid
01/05/2010US7641702 O-Aminophenol derivatives and colorants containing said compounds